Toxic Shock Syndrome News and Research

RSS
Toxic Shock Syndrome is a serious illness most often caused by the bacteria Staphylococcus aureus and less commonly Streptococcus pyogenes (group A streptococci) both of which can produce "toxins." TSS was first recognized in 1978 and was later associated with tampon use in adolescents and young menstruating women in the majority of those cases. TSS is now known to be associated with other risk factors such as surgical wounds and childbirth. TSS has a rapid onset characterized by fever, low blood pressure, kidney failure, and multi-system organ involvement. Profuse watery diarrhea, vomiting and rash are usually present with Staphylococcus aureus TSS, but less commonly with Streptococcus pyogenes (group A streptococci) TSS.
Chronic exposure to bacteria may lead to development of Type 2 diabetes

Chronic exposure to bacteria may lead to development of Type 2 diabetes

Alere i Strep A test receives marketing clearance from FDA

Alere i Strep A test receives marketing clearance from FDA

Roche announces launch of cobas Liat System for on-demand testing in different settings

Roche announces launch of cobas Liat System for on-demand testing in different settings

Researchers reveal importance of highly specialised immune cells in killing melanoma cells

Researchers reveal importance of highly specialised immune cells in killing melanoma cells

Findings provide new strategy for developing safe, effective vaccine against strep throat

Findings provide new strategy for developing safe, effective vaccine against strep throat

Scientists discover novel mechanism that influences GAS virulence at early steps of necrotizing fasciitis

Scientists discover novel mechanism that influences GAS virulence at early steps of necrotizing fasciitis

Research may lead to potential treatment for deadly bacterial infections

Research may lead to potential treatment for deadly bacterial infections

Research opens way to possible new treatments for bacterial infections

Research opens way to possible new treatments for bacterial infections

‘Flesh-eating’ disease treatments: an interview with Dr. John Crew, Seton Medical Center

‘Flesh-eating’ disease treatments: an interview with Dr. John Crew, Seton Medical Center

Interaction between fat cells and bacterial toxins can lead to chronic inflammation

Interaction between fat cells and bacterial toxins can lead to chronic inflammation

Study shows superantigens produced by staph bacteria cause infective endocarditis and sepsis

Study shows superantigens produced by staph bacteria cause infective endocarditis and sepsis

Wisconsin scientists synthesize potent compounds to curb bacteria that cause staph infections

Wisconsin scientists synthesize potent compounds to curb bacteria that cause staph infections

Certain strains of lactobacillus bacteria can dampen production of toxic shock syndrome toxin 1

Certain strains of lactobacillus bacteria can dampen production of toxic shock syndrome toxin 1

WomanCare Global, Evofem enter strategic alliance

WomanCare Global, Evofem enter strategic alliance

Study suggests that existing HIV drug could be a potential therapy for Staph infections

Study suggests that existing HIV drug could be a potential therapy for Staph infections

FDA clears Meridian Bioscience’s new illumigene Group A Strep test

FDA clears Meridian Bioscience’s new illumigene Group A Strep test

Scientists discover structure and operating procedures of anti-bacterial killing machine

Scientists discover structure and operating procedures of anti-bacterial killing machine

Study explores role of L. reuteri against foodborne infection

Study explores role of L. reuteri against foodborne infection

Vaxent, PREVENT sign license agreement to develop and commercialize Strep-A vaccine

Vaxent, PREVENT sign license agreement to develop and commercialize Strep-A vaccine

Insight into how bacterial toxins cause human diseases may help improve treatment

Insight into how bacterial toxins cause human diseases may help improve treatment